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In eukaryotes, ribonuclease H1 (RNase H1) is involved
in the processing and removal of RNA/DNA hybrids in
both nuclear and mitochondrial DNA. The enzyme
comprises a C-terminal catalytic domain and an N-ter-
minal hybrid-binding domain (HBD), separated by a
linker of variable length, 115 amino acids in Drosophila
melanogaster (Dm). Molecular modelling predicted this
extended linker to fold into a structure similar to the
conserved HBD. Based on a deletion series, both the
catalytic domain and the conserved HBD were required
for high-affinity binding to heteroduplex substrates,
while loss of the novel HBD led to an 90% drop in
Kcat with a decreased KM, and a large increase in the
stability of the RNA/DNA hybrid-enzyme complex,
supporting a bipartite-binding model in which the se-
cond HBD facilitates processivity. Shotgun proteomics
following in vivo cross-linking identified single-stranded
DNA-binding proteins from both nuclear and mitochon-
drial compartments, respectively RpA-70 and mtSSB,
as prominent interaction partners of Dm RNase H1.
However, we were not able to document direct and sta-
ble interactions with mtSSB when the proteins were co-
overexpressed in S2 cells, and functional interactions
between them in vitro were minor.
Keywords: biolayer interferometry; mitochondria;
ribonuclease H; shotgun proteomics; single-stranded
DNA-binding protein.
Abbreviations: BLI, biolayer interferometry; Dm,
Drosophila melanogaster; EMSA, electrophoretic
mobility shift assay; GMQE, global model quality
estimation; HBD, hybrid-binding domain; LB, L-
broth; mtDNA, mitochondrial DNA; PDB, protein
data bank; RNase H1, ribonuclease H1; rnh1, ribo-
nuclease H1 (Drosophila gene name); RPA, replica-
tion protein; TFAM, mitochondrial transcription
factor A; TBE, Tris-borate-EDTA buffer; YFP, yel-
low fluorescent protein.
In eukaryotes, ribonuclease H1 (RNase H1) is present
both in mitochondria and in the nucleus, as distinct
translation products encoded by a single mRNA
(1, 2). The enzyme digests the RNA strand of RNA/
DNA heteroduplexes longer than 4 bp (3) and has
been implicated in diverse DNA transactions in one
or both cellular compartments, including DNA repli-
cation (2, 4–10), transcription (11–13), recombination
(14, 15), repair (16, 17) and telomere maintenance (18,
19). The targeting of the enzyme to two cellular com-
partments complicates functional studies. Therefore,
our understanding of its biology has instead relied
heavily on biochemical analysis.
Eukaryotic RNase H1 presents a conserved domain
organization (20). A nucleic acid-binding motif,
denoted the hybrid-binding domain (HBD), which is
also found in some bacteria such as Bacillus halodur-
ans (21), is located near the N-terminus. The catalytic
conserved HBD        second HBD                   catalytic domain
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(RNase H) domain is found near the C-terminus, with
an extended linker (or connection domain) located be-
tween these two domains. In human RNase H1, the
HBD not only confers tight binding to RNA/DNA
hybrid but also interacts weakly with dsRNA and
even more weakly with dsDNA (22). Portions of its
structure that interact with RNA and with DNA have
been mapped precisely (22). However, the physiologic-
al or mechanistic role(s) of the HBD are not fully
understood. It has been suggested to promote dimer-
ization, conferring processivity to the enzyme (23) and
interactions with other proteins (24). Since the first
RNase H structure from bacteria was elucidated in
1990 (25, 26), a conserved three-dimensional organiza-
tion has been observed in homologs of the enzyme
from eukaryotes (27), prokaryotes (28, 29) and viruses
(30–32). This specific structure involves four residues
in close proximity, the DEDD motif (33), serving as
the catalytic core of the enzyme (see Supplementary
Fig. S1F). The catalytic domain of human RNase H1
has been studied extensively with respect to its binding
affinity (34), cofactor requirements and structure (27).
Among eukaryotes, the extended linker that connects
the HBD and RNase H (catalytic) domains is the least
phylogenetically conserved portion of the protein,
both in length and primary sequence (Fig. 1) (35). The
human linker spans 64 amino acids, whereas it is 48
residues long in Caenorhabditis elegans and 115 in
Drosophila melanogaster (Dm). The current view is
that the extended linker of the human enzyme confers
flexibility to the RNase H domain whereas the HBD
remains bound to the substrate (20); however, the
variability of the linker among species remains
unexplained.
The ribonuclease H1 (rnh1) gene is necessary for
pupal development in Dm (36). Rnaseh1 knockout
mice also exhibit developmental lethality, with severe-
ly decreased copy number of mitochondrial DNA
(mtDNA), suggesting an essential role of RNase H1
in mtDNA maintenance (5). Several point mutations
in the human RNASEH1 gene are associated with














































































Fig. 1. Drosophila melanogaster RNase H1 protein sequence organization and structure. (A) Schematic representation of RNase H1 enzyme
among different species (Drosophila melanogaster, Homo sapiens, Rattus norvegicus, Xenopus tropicalis, Danio rerio, Caenorhabditis elegans,
Saccharomyces cerevisiae and Escherichia coli). Black box represents the conserved HBD and the empty box the catalytic domain. Length of
the linker region (in amino acids) for each species is shown. Note that S. cerevisiae has two HBDs and two linkers (57). (B) Schematic repre-
sentation of different Dm RNase H1 protein variants created in the study: RNase H1 (Rnh1, NCBI AAF59170.1 amino acids 17–333), DI/II
(87–333), DII/III (17–65 þ 142–333), DI–III (142–333), DI–IV (179-333), DIII/IV (17–87 þ 179–333), DII–V (17–65), DIII–V (17–87), DI/II–
IV/V (87–137) and DIV/V (17–142). The whole RNase H1 protein sequence has been divided into five regions (assumed to represent protein
domains) bounded by amino acids 17, 65, 87, 142, 179 and 333. Black boxes represents the conserved HBD, the hatched boxes the second
predicted HBD and the empty boxes the catalytic domain. (C) Purified proteins, as indicated, separated by SDS-PAGE and Coomassie stain-
ing, alongside molecular mass (MW) markers in kDa. Based on purity assessment (see Experimental Procedures) and overall protein concen-
trations, the effective amounts of each variant were estimated as follows: RNase H1 1.0 mg, DI/II 1.0 mg, DII/III 2.0 mg, DI–III 1.7 mg, DII–
V 3.2 mg, DIII–V 4.8 mg and DIV/V 2.9 mg.
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syndromic disorder associated with mutations in vari-
ous mtDNA maintenance proteins, such as the mito-
chondrial DNA polymerase gamma (Polc) (40) or
mitochondrial transcription factor A (TFAM) (41).
Being targeted both to mitochondria and to the nu-
cleus (1, 2), RNase H1 has been implicated in RNA/
DNA turnover in both compartments (8, 42, 43). In
mitochondria, heteroduplex turnover impacts mtDNA
replication initiation and segregation (2, 7, 44) as well
as mitochondrial RNA processing (2, 13, 45), while in
the nucleus, it also affects DNA repair (16, 46) and
telomere maintenance (18).
It remains unclear whether the lethality associated
with rnh1 deletion in Drosophila (36) is due to a re-
quirement for its function in the nucleus, in mitochon-
dria or both. Recently, we described the effects of
Drosophila rnh1 downregulation, which triggers
decreased lifespan, mitochondrial dysfunction and
mtDNA depletion (2). This phenotype was associated
with abnormalities in mtDNA replication, notably at
the origin and in regions where the transcription ma-
chinery progresses in the opposite direction to that of
DNA replication (2).
In the present study, in view of the preliminary find-
ings of previous investigators (47), we set out to deter-
mine the biochemical properties of the different
domains of Dm RNase H1, notably that of the
extended linker, via functional studies of a deletion
series in vitro, and by screening for interacting pro-
teins. This leads us to propose a new conceptual
mechanism facilitating the processivity of the enzyme,
as well as an interaction with mitochondrial single-
stranded DNA-binding protein (mtSSB) that appears
to be robust but indirect.
Materials and Methods
Molecular modelling
Dm RNase H1 protein structure was modelled by SWISS-MODEL
(Biozentrum, University of Basel, Switzerland) (48–50). Its amino
acid sequence was first compared with those of proteins from the
protein data bank (PDB) that have crystallographically determined
structures. Potential templates were then ranked, based on estimated
GMQE (global model quality estimation). Model quality was
assessed by QMEAN, a value calculated by global and local geo-
metrical characteristics of the model with respect to the template.
Models were analysed and visualized by PyMol (Schrödinger).
Cloning into expression vectors
rnh1 and mtSSB cDNAs were derived by PCR using methods
described previously (2) and primers as listed in Supplementary
Table S1. The rnh1 cDNA was cloned into pET-26b(þ) (Novagen,
Merck Millipore) for bacterial expression with an in-frame C-ter-
minal 6x-His tag. Partially deleted rnh1 variants (Fig. 1B) were gen-
erated by a two-step PCR procedure, as described previously (2).
PCR-based site-directed mutagenesis was used to create variant
cDNAs bearing the D252N point mutation, predicted to abolish nu-
clease activity in RNase H1. For expression in Drosophila S2 cells
(51), the mtSSB coding sequence was cloned into pMT-puro
(Addgene) using a two-step procedure. It was first amplified and
inserted into pMT/V5-His B (ThermoFisher Scientific), using pri-
mers that introduced EcoRI and XhoI restriction sites, then
recloned into pMT-puro using primers that added KpnI and PmeI
restriction sites, also eliminating the V5-His tag but adding a C-ter-
minal HA [(amino acids 98-106) derived from human influenza
hemagglutinin] tag in its place (see Supplementary Table S1).
Successfully transfected colonies were selected by plating on 0.5lg/
ml puromycin (InvivoGen). All plasmids were sequenced before use.
Protein expression and purification
Competent BL21 StarTM (DE3) Escherichia coli cells (ThermoFisher
Scientific) were transformed with pET-26b(þ)-derived DNA con-
structs using heat shock and selected on 50lg/ml kanamycin plates.
Cells from single colonies were grown overnight in 200ml L-broth
(LB, 1% tryptone, 1% NaCl, 0.5% yeast extract, all w/v), supple-
mented with 50lg/ml kanamycin, at 37C with shaking at 250 rpm.
The culture was then diluted into 4 l of LB (in eight 2-l Erlenmeyer
flasks) and incubated at 37C with shaking until it reached an
OD600 of 0.7. Protein expression was induced by the addition of
IPTG (isopropyl b-D-1-thiogalactopyranoside) to 400mM and a fur-
ther incubation for 3 h. Cells were harvested by 10-min centrifuga-
tion at 5,000 gmax and stored at 80C. Bacterial pellets were
thawed in ice-cold resuspension buffer (30mM Tris-HCl, 200mM
KCl, 2mM DTT, 10% glycerol, pH 8.0) containing, per 25ml, one
cOmpleteTM EDTA-free Protease Inhibitor Cocktail tablet (Roche).
Lysozyme (Invitrogen) was added to 200lg/ml on ice for 40min,
after which cells were lysed by three rounds of sonication on ice,
using a Vibra Cell (VC) 505 sonicator (Sonic & Materials, Inc.), fit-
ted with a 13-mm probe, set to 60% amplitude with a 1 s/2 s on/off
cycle for 3min. Where needed, a fourth round of sonication was
added. The lysate was ultracentrifuged at 100,000 gmax for 30min at
4C, after which the supernatant was filtered through a 0.45-mm
nylon syringe filter (GE Healthcare WhatmanTM Uniflo) and loaded
dropwise overnight onto a 3-ml Ni-NTA agarose (ThermoFisher
Scientific) column (Qiagen 30230) pre-washed in water then pre-
equilibrated with equilibration buffer (30mM Tris-HCl, 200mM
KCl, 2mM DTT, 10% glycerol, 5mM imidazole, pH 8.0, plus the
protease inhibitor). All chromatography and gel filtration steps were
conducted at 4C. Non-specifically bound proteins were removed by
successively washing with 15ml buffer 1 (30mM Tris-HCl, 200mM
KCl, 2mM DTT, 10% glycerol, 25mM imidazole, pH 8.0, plus the
protease inhibitor) and 15ml buffer 2 (30mM Tris-HCl, 200mM
KCl, 2mM DTT, 10% Glycerol, 50mM imidazole, pH 8.0, with
same protease inhibitor), after which the desired protein was finally
eluted with 6ml buffer 3 (30mM Tris-HCl, 1M KCl, 2mM DTT,
10% glycerol, 250mM imidazole, pH 8.0, plus the protease inhibi-
tor) and collected in 0.5-ml aliquots. Fractions containing the
desired protein were pooled, and gel filtration was performed on
Superdex 75 or 200 10/300 GL columns (GE Healthcare) mounted
into an ÄKTA P100 chromatography system (GE Healthcare).
Columns were washed and equilibrated with SE buffer (30mM
Tris-HCl, 200mM KCl, 2mM DTT, 10% glycerol, pH 8.0), and
0.5ml fractions were collected after sample injection. All proteins
eluted as a single peak, consistent with their inability to form multi-
mers in the absence of substrate. Protein concentrations were deter-
mined using the Bradford assay and protein purity assessed by
SDS-PAGE on 12.5% or 15% polyacrylamide gels, followed by
Coomassie-Blue staining, with signal from the main band divided
by the combined signal from all visible bands, using ImageJ soft-
ware. The effective concentration of each variant was then inferred
from these purity values. Protein concentrations used in subsequent
assays were adjusted accordingly. The purified proteins were ali-
quoted and stored at 80C. Drosophila mtSSB was expressed and
purified as described previously (52).
Nucleic acid substrates
RNA and DNA oligonucleotides used for the experiments are listed
in Supplementary Table S1. For testing nuclease activity, DNA or
RNA oligonucleotides were 50 radiolabelled with [c-32P]-ATP
(PerkinElmer, 3,000Ci/mmol), using T4 Polynucleotide Kinase
(New England Biolabs) as described in manufacturer’s protocol.
The radiolabelled nucleic acid was recovered by gel-filtration using
a Sephadex G-50 fine Quick Spin column (Roche) according to
manufacturer’s instructions, and its concentration was estimated by
scintillation counting. To generate a double-stranded substrate, a 2-
fold excess of the complementary strand was added and incubated
for 5min in annealing buffer (90mM Tris-HCl, 10mM MgCl2,
50mM KCl, pH 8.0) at 95C, then bench-cooled to room
temperature.
Nuclease activity assay
Radiolabelled substrate was incubated with purified Dm RNase H1,
variants or control enzymes as described below and in figure
legends, and at the indicated temperatures, in reaction buffer
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serum albumin (BSA), pH 8.0) with salt concentration adjusted to
25mM KCl. Positive control enzymes (ThermoFisher Scientific)
were selected according to the substrate: for linear RNA/DNA
hybrids and R-loops, RNase H; for dsRNA and ssRNA, RNase A;
and for dsDNA and ssDNA, DNase I. Reactions were stopped with
10 STOP solution (10% SDS (w/v), 100mM EDTA), incubated
for 10min at 60C, separated by non-denaturing polyacrylamide gel
[1 TBE (Tris-borate-EDTA buffer), 12.5% acrylamide:bis-
acrylamide 19:1] electrophoresis and heat/vacuum dried for auto-
radiography (Amersham Hyperfilm ECL, GE Healthcare). Images
were analysed densitometrically using ImageJ. For calculating turn-
over kinetics, initial cleavage rates (V0) were calculated for each
RNase H1 variant at 0.2 nM, in the presence of different concentra-
tions of radiolabelled hybrid (2.5, 5, 7.5 and 10nM) at different
time points. Product generation was plotted as a function of time
and V0 was calculated by estimating the time required to obtain
10% product. V0 was plotted against substrate concentration and
fitted to the Michaelis–Menten equation. Kinetic constants were
estimated by the Lineweaver–Burk equation.
Electrophoretic mobility shift assay
Binding reactions were conducted in binding buffer (25mM Tris-HCl,
1mM DTT, 10mM EDTA, 20lg/ml BSA, pH 8.0) and salt was
adjusted to a final concentration of 25mM KCl. Protein and nucleic
acid concentrations were as indicated in figure legends. Samples were
incubated at room temperature for 30min and fractionated by 6%
polyacrylamide gel (0.5 TBE, 6% acrylamide:bis-acrylamide 29:1,
2.5% glycerol) electrophoresis in TBE buffer. Non-radiolabelled nu-
cleic acid was stained with GelREDTM (Biotium) for 20min in TBE
and washed for 20min with TBE. Gel images were analysed with
ImageJ.
Biolayer interferometry
50-Biotinylated (RNA or DNA) oligonucleotides (Sigma,
Supplementary Table S1) were diluted with non-biotinylated com-
plementary oligonucleotides in PBS, each at a concentration of
10mM. The oligonucleotide mixture (dsDNA, dsRNA or RNA/
DNA hybrid) was incubated at 95C for 5min and left to anneal at
room temperature overnight. Streptavidin-coated biosensors
(FortéBio) were humidified for 30min in water. This and all subse-
quent steps were conducted in 384-well plates using 80ll of solution
per well. Sensors were transferred to 25 nM annealed, biotinylated
nucleic acid solution for 5min, followed by a quenching step with
10mg/ml Biocytin (Sigma) diluted in PBS. Sensors were blocked and
equilibrated with Kinetics Buffer (30mM Tris-HCl, 100mM KCl,
10% glycerol, 10mM EDTA, 2mM DTT, 400mg/ml BSA, pH 8.0)
twice for 10min. Sensors were transferred to Kinetics Buffer con-
taining different protein concentrations for 15min. Dissociation was
measured using an Octet
VR
RED384 biolayer interferometry (BLI)
detection system (FortéBio), by transferring the sensors to Kinetics
Buffer for 15min. All steps were conducted at 30C with mixing at
1,000 rpm. Processing and analysis of the data were as described
(53), using Octet
VR
Systems software (FortéBio). Monovalent (1:1)
or heterogeneous (2:1) binding models were used for estimating
equilibrium dissociation constant (KD), association rate (Kon) and
dissociation rate (Koff), as indicated in figures and tables for each
variant.
Immunocytochemistry
S2 cell transfection, fixation, staining and imaging were as described
previously (2). mtYFP and mtSSB-HA were detected using mouse
monoclonal antibodies, respectively, against GFP (Abcam ab1218,
1:10,000), and HA tag (2-2.2.14; ThermoFisher Scientific 26183,
1:10,000), used with goat anti-mouse IgG AlexaFluor
VR
568
(ThermoFisher Scientific A-11004, 1:10,000) as secondary antibody.
Mitochondrial Cox4 was counter-stained with rabbit polyclonal
anti-COXIV antibody (Abcam ab16056, 1:10,000), used with goat
anti-rabbit IgG AlexaFluor
VR
488 (ThermoFisher Scientific A-11008,
1:10,000) as secondary antibody. Images were optimized for bright-
ness and contrast using ImageJ but not manipulated in any other
way.
Immunoprecipitation from S2 cells
Stably transformed S2 cell-derived cell lines were generated (2)
and maintained (51), and protein expression induced as described
previously (2). Immunoprecipitation was conducted essentially as
described previously (54), using five independent biological repli-
cates from each variant. Approximately, 6  108 cells were cross-
linked with 1% formaldehyde for 10min at room temperature with
continuous agitation. Cross-linking was stopped by adding 125mM
glycine. Cells were harvested by centrifugation, washed four times
with ice-cold Tris-buffered saline, resuspended in RIPA lysis buffer
(50mM Tris-HCl, 150mM NaCl, 1% v/v Nonidet P40; 0.5% w/v
sodium deoxycholate; 0.1% w/v SDS, pH 7.6) and incubated for
30min on ice. Cells were water-bath sonicated (FinnSonic M0,
ultrasonic power 200W, ultrasonic frequency 40 kHz) at 4C for
20min. Cell extracts were incubated at 37C for 30min following
the addition of RNase A (ThermoFisher Scientific, 100lg/ml),
DNase I (ThermoFisher Scientific, 5U/ml), Benzonase
VR
nuclease
(Sigma, 50U/ml), MgCl2 to 2.5mM and CaCl2 to 1mM. Samples
were centrifuged for 10min at 4C, after which supernatants were
incubated with 3 ll anti-V5 (Invitrogen R-960-25) or anti-HA
(Invitrogen 26183) antibody overnight at 4C on a rocking shaker.
Protein–antibody complexes were collected by incubating protein
extracts with 20ll SureBeads Protein G magnetic beads (Bio-Rad)
for 30min at room temperature on a rocking shaker, followed by
three washes with RIPA buffer and resuspension of magnetic beads
in protein-loading buffer (PLB: 2% w/v SDS; 2mM b-mercaptoe-
thanol, 4% v/v glycerol, 40mM Tris-HCl, 0.01% w/v bromophenol
blue, pH 6.8). Cross-linking was reversed by heating at 95C for
30min. Samples were analysed by mass-spectrometry, as below, or
by Western blotting, essentially as described previously (2), using
the following primary/secondary antibodies: rabbit anti-6x-His Tag
(ThermoFisher Scientific PA1-983B, 1:10,000), mouse monoclonal
anti-GFP [Abcam ab1218, 1:10,000, used to detect yellow fluores-
cent protein (YFP)] and mouse monoclonal anti-HA Tag
(ThermoFisher Scientific 26183, 1:10,000), used with either IRDve
VR
680LT anti-mouse (LI-COR, 925-68022, 1:10,000) or IRDve
VR
680LT anti-rabbit (LI-COR, 925-68023, 1:10,000), as appropriate.
Blot images were cropped and rotated for presentation, and opti-
mized for contrast and brightness, but not subjected to other
manipulations.
Liquid chromatography coupled to tandem mass
spectrometry
Liquid chromatography coupled to tandem mass spectrometry (LC-
MS/MS) was carried out on an EASY-nLC1000 chromatograph
connected to a Velos Pro-Orbitrap Elite hybrid mass spectrometer
with nano-electrospray ion source (all instruments from
ThermoFisher Scientific). The LC-MS/MS samples were separated
using a two-column setup, consisting of a 2-cm C18 Pepmap column
(#164946, ThermoFisher Scientific), followed by a 15-cm C18
Pepmap analytical column (#164940 ThermoFisher Scientific).
Samples were loaded in buffer A and the linear separation gradient
consisted of 5% buffer B for 5min, 35% buffer B for 60min, 80%
buffer B for 5min and 100% buffer B for 10min at a flow rate of
0.3ll/min (buffer A: 0.1% trifluoroacetic acid in 1% acetonitrile;
buffer B: 0.1% trifluoroacetic acid in 98% acetonitrile). Six micro-
litres of sample was injected per LC-MS/MS run and analysed. Full
MS scans were acquired with a resolution of 60,000 at 300–1,700m/
z range in the Orbitrap analyser. The method was set to fragment
the 20 most intense precursor ions with CID (energy 35). Data were
acquired using LTQ Tune software. Acquired MS2 scans were
searched against the Dm protein database [(55) Uniprot 2017; with
41,170 entries] using the Sequest search algorithms in Thermo
Proteome Discoverer (version 1.4). All data were reported based on
95% of confidence for protein identification, i.e. a false discovery
rate of 5% was applied. Allowed mass error for the precursor ions
was 15 ppm, and for the fragment 0.8Da. A static residue modifica-
tion parameter was set for carbamidomethyl þ57,021Da (C) of
cysteine residue. Methionine oxidation was set as dynamic modifica-
tion þ15,995Da (M). Only full tryptic peptides were allowed, with a
maximum of one missed cleavage.
Results
Structure modelling of Dm RNase H1
Dm RNase H1 was previously proposed to comprise
three structural elements (47): an N-terminal HBD do-
main similar to a region of caulimovirus ORF VI pro-
tein (56), an RNase H catalytic domain located
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towards the C-terminus and a 115-amino acid
extended linker that connects these domains.
Although the extended linker is longer, the overall
architecture is similar to that of RNase H1 from other
eukaryotes (Fig. 1A) (20). Structure modelling of the
Drosophila sequence revealed conserved and potential-
ly novel features of the enzyme. Two of the four
amino acids of the human HBD required for hybrid
binding (22) are conserved, namely Y29 and K60,
contacting the DNA backbone, equivalent to Y19 and
K50 in the fly enzyme (Supplementary Fig. S1A). The
main-chain amides of human R52 and A55 form
hydrogen bonds with 20-OH groups from two con-
secutive ribonucleotides. These amino acids are
replaced in Drosophila by G42 and N45. The DEDD
motif at the catalytic core (33) is also present in
Drosophila at positions D187, E228, D252 and D318
(Supplementary Fig. S1D and F) as are two of the
three amino acids of the catalytic domain involved in
hybrid binding (27) in human, i.e. N151 and N182
(N193 and N224 in Drosophila), while the third,
human Q183 is represented in Drosophila as N225.
Protein structure modelling software predicted that a
portion of the extended linker could fold as an add-
itional HBD (amino acids 87–142, Supplementary
Fig. S1B and C). The conserved N-terminal HBD
(amino acids 17–64) shows 42% sequence identity
with human RNase H1, with a QMEAN (estimated
value of the geometric properties of the model) of 0.55
and a GMQE (being a quality estimation that merges
properties of the sequence-template alignment and the
template search method) of 0.18. The second predicted
HBD has only 24% sequence identity, a QMEAN of
3.32 and GMQE of 0.08 (48–50). The conserved
HBD shows a similar structure as in human (22), with
two a-helices and three antiparallel b-sheets, organized
as a bbaba structure. The second predicted HBD is
similar, but with longer loops connecting b1 to b2 and
a1 to b3. The presence of an additional HBD-like do-
main has previously been reported in Saccharomyces
cerevisiae (35, 57), where it stabilizes interaction with
dsRNA. These observations prompted us to explore
the binding properties of the different domains of the
Drosophila enzyme.
Enzymatic properties of Drosophila RNase H1
To explore its biochemical properties, the full-length
Dm RNase H1 protein was expressed in E. coli. The
expressed protein consisted of 316 amino acids from
the RNase H1 open-reading frame, commencing at
A17, assuming post-translational removal of the N-
terminal formyl-methionine by the action of methio-
nine aminopeptidase (58), plus an additional eight
amino acids at the C-terminus from the 6x-His tag
and two further amino acids contributed by the vec-
tor, pET-26b(þ). This expressed protein represents
the nuclearly targeted variant, which is very similar to
the mitochondrially targeted variant after removal of
the predicted mitochondrial targeting signal.
Following affinity purification and size-exclusion
chromatography, it migrated on SDS-PAGE gels with
an apparent molecular mass of 38 kDa (Fig. 1C),
close to prediction (35.1 kDa plus the C-terminal tag).
We initially investigated the kinetic properties of the
enzyme at 30C, using a blunt-ended model substrate
comprising a 5-radiolabelled 30 nt RNA oligonucleo-
tide hybridized to a complementary 30 nt DNA oligo-
nucleotide (Table I; for original gels and graphical
plots see Supplementary Fig. S2A–C). For compari-
son with the previously studied human enzyme, we
reinvestigated RNase H1 from the two species at both
30 and 37C. At 30C, the human enzyme had no de-
tectable activity, while at 37C it performed as previ-
ously reported (34), validating the methods employed.
The Drosophila enzyme showed a greatly increased
KM but also an approximate doubling of Kcat at 37
C,
compared with its properties at 30C. Note that 37C
is far above the physiological temperature range for
the fly enzyme in vivo (15–30C). In comparison with
the human enzyme at 37C, the Drosophila enzyme at
30C can be regarded as considerably more active,
with a much lower KM and much higher Kcat (Table I
and Supplementary Fig. S2). The prediction of a se-
cond HBD and the high enzymatic activity of the en-
zyme in vitro prompted us to look next at its ability to
bind RNA/DNA hybrid.
Hybrid-binding properties of Dm RNase H1
To study the binding of Dm RNase H1 and its deriva-
tives to nucleic acid substrates, we generated a single
point mutation (D252N) at the catalytic core, which
abolished enzymatic activity (Fig. 2A). This enabled
us to use an electrophoretic mobility shift assay
(EMSA) to profile qualitatively its nucleic acid-
binding properties. A 10-fold molar excess of the pro-
tein was sufficient to generate a detectable complex
with a 30-bp RNA/DNA hybrid, with a secondary
mobility shift seen at higher protein/hybrid ratios
(Fig. 2B). Trials with substrates of different lengths
down to 22 bp also revealed a second mobility shift at
high protein concentrations (Supplementary Fig.
S2D), suggesting the formation of higher-order com-
plexes, most likely two protein moieties with one sub-
strate. Substrate-binding kinetics were then analysed
quantitatively in real time by BLI, the degree of reso-
lution by EMSA being insufficient to extrapolate kin-
etic parameters (53).
The RNA/DNA hybrid substrate was immobilized
on the sensors and the binding of the enzyme at vari-
ous concentrations was analysed. The shapes of the
association and dissociation curves (Fig. 2C) suggest
heterogeneous binding, which was also inferred by the
instrument software, fitting the data preferentially to a
2:1 binding model, i.e. with the enzyme binding in two
steps to the substrate. The estimated affinity of the
first binding step was relatively low, with KD ¼
5506 24 nM, but much stronger in the second, with
KD ¼ 0.236 0.063 nM (Table II). These data suggest
that the first binding step represents substrate recogni-
tion, whereas the second step likely stabilizes the en-
zyme on the substrate. For comparison, the KD for
the second binding step is 10-fold lower than that
reported for mtSSB from Dm in its binding to ssDNA
(2.5 nM) (59). To dissect these findings in more detail
and relate them to the structure of the enzyme, we
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properties of Dm RNase H1 variants bearing deletions
of specific domains.
The HBD domains influence Dm RNase H1 activity
For the purposes of this analysis we defined five
regions of the enzyme, from N- to C-terminus
(Fig. 1B), as follows: Region I is the conserved HBD
(amino acids 17–64), Region II (amino acids 65–86) is
the short linker leading up to the second predicted
HBD, Region III (amino acids 87–141). Region IV is
another short linker (amino acids 142–178), leading
up to Region V, the RNase H catalytic domain
(amino acids 179–333). Variants lacking Region IV
but retaining Region V, as well as the one comprising
only Region III, were insoluble, even when expressed
using an auto-induction system and tested under dif-
ferent buffer conditions (salt, pH), and thus were not
studied further. All purified variant proteins migrated
on SDS-PAGE gels approximately as predicted
(Fig. 1C). The measured kinetic parameters of those
variants that retained detectable catalytic activity are
indicated in Table I (Supplementary Fig. S2). In sum-
mary, deletion of Regions I–III (DI–III) or of just the
conserved HBD and its adjacent linker (DI/II) facili-
tated catalysis (Fig. 3A), though with subtly different
effects on the kinetic parameters (Table I and
Supplementary Fig. S2), whereas deletion of just the
second predicted HBD and its upstream linker (DII/
III) caused almost a 90% decrease in Kcat at 30
C,
despite a decreased KM (Table I, Fig. 3A and
Supplementary Fig. S2). In more general terms, the
conserved HBD, whenever it was present, appeared to
restrain catalysis. However, the second HBD miti-
gated this effect. Both the I/II and II/III regions
decreased substrate binding to the catalytic centre, as
inferred from lower KM values in their absence. This
might be a simple consequence of the presence of add-
itional binding steps preceding the loading of the sub-
strate to the catalytic centre. In addition, the II/III
region appears to support an efficient turnover rate,
as its absence results in a decrease of the Kcat value by
8-fold (Table I). A simultaneous decrease in both
KM and Kcat, as observed in the absence of the II/III
region (Table I), is indicative of a decreased rate of
dissociation of the enzyme-product complex. In turn,
this implies that the second HBD may be relevant for
effective product release. Given that the RNase has to
progress along the substrate, the binding properties
of Region III might be relevant to the translocation
process. The lack of both HBD domains resulted in a
>2-fold increase in turnover rate (Table I), which
implies that substrate binding by the HBD
domains together limits the rate of catalysis. To ex-
plore this further, we then looked at the hybrid-
binding properties of the variants lacking either or
both HBDs.
Hybrid-binding properties conferred by the HBDs
We proceeded to test the hybrid-binding properties of
these variants by introducing the D252N mutation.
Analyses by EMSA (Fig. 3B) and BLI (Fig. 3C and
Table II) showed that the ability to bind RNA/DNA
hybrid was retained when the conserved (DI/II
D252N) or second HBD (DII/III D252N) were
deleted, or even when both HBDs were deleted (DI–
III D252N). However, the kinetic parameters of the
binding reactions, as inferred by BLI, indicated a dif-
ference in the nature of the binding to the two HBDs.
Wherever the conserved HBD was missing, the senso-
gram indicated a 1:1 substrate-binding model (Fig. 3
and Table III), rather than the 2:1 model (Figs 2 and
3 and Table II) that was more compliant with the
data from full-length RNase H1 or the variant lacking
only the second HBD (DII/III D252N). The ‘super-
shift’ band observed by EMSA with the full-length
protein at high protein:substrate ratio (Fig. 2B and
Supplementary Fig. S2D) was also abolished when the
conserved HBD was absent (Fig. 3B).
The deletion of region I/II (conserved HBD)
resulted in an 35% decrease in substrate-binding af-
finity (compare Fig. 3C and D, Table III with Fig. 2C,
Table II), consistent with the role of this domain in
substrate binding inferred from the lower KM.
Conversely, the lack of region II/III (the second
HBD) substantially increased substrate affinity (5-
fold). Taken together with the decreased Kcat, this
strengthens the case that the second HBD is needed
for efficient substrate release and thus, most likely, for
the enzyme’s translocation along the substrate. The
full N-terminal region (I–III) truncation behaved in a
similar manner to the variant lacking only the con-
served HBD (Table III), implying that the second
HBD only functions in co-operation with the first. As
RNase H1 must interact with a template composed
mostly of dsDNA, and which is also actively tran-
scribed, we next investigated whether the Drosophila
enzyme was able to bind to other nucleic acid sub-
strates than RNA/DNA hybrid.
Binding of Dm RNase H1 to other nucleic acid
substrates
We next considered the broader nucleic acid-binding
properties and substrate preferences of the enzyme.
EMSA analysis using the D252N-substituted var-
iants revealed that the full-length protein as well as
deletion constructs lacking the second HBD (DII/III)
were able to bind both dsDNA (Fig. 4A) and
dsRNA (Fig. 4B), although this binding was weak-
ened substantially when the conserved HBD (DI/II)
or both HBDs (DI–III) were deleted (Fig. 4A and B).
An R-loop substrate was bound by all of these con-
structs, including the catalytic domain alone,
Table I. Estimated kinetic parameters
a
of RNase H1 and variants
Enzyme KM (nM) Kcat (min
21)
Human RNase H1 (37C) 42 6 8.2 3.0 6 1.5
Dm RNase H1 (37C) 170 6 5.7 27 6 2.5
Dm RNase H1 (30C) 8.5 6 1.8 13 6 3.3
DI/II (30C) 4.0 6 1.1 13 6 7.7
DII/III (30C) 3.1 6 0.55 1.6 6 1.6
DI–III (30C) 9.7 6 1.8 30 6 9.0
Dm RNase H1 D252N (30C) 0 0
aMeans 6 SD (n 3) for Dm and human enzymes and variants.
All values are given to two significant figures.
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together with the preceding short linker (DI–III;
Fig. 4C), and in each case a supershift was observed
at high protein concentration (Fig. 4C). BLI
(Table II) confirmed these findings, although the de-
letion of the second HBD increased the binding af-
finity for dsDNA, but not dsRNA (Supplementary
Figs S3 and S4). The affinity of all of the tested var-
iants for RNA/DNA hybrid was at least 1–2 orders
of magnitude greater than for dsRNA or dsDNA
(Tables II and III). Neither the full-length D252N-
substituted protein, nor any of the variants tested,
had any detectable affinity for ssRNA or ssDNA
(Supplementary Fig. S5) nor did the equivalent var-
iants without the D252N substitution show any de-
tectable nuclease activity against dsDNA (Fig. 4D),
dsRNA (Fig. 4E), ssDNA (Fig. 4F) or ssRNA
(Fig. 4G). Removal of the second HBD appeared to
have a negative effect on catalytic activity using the
R-loop substrate (Fig. 4H), although removal of the
conserved HBD had no major effect on this activity,
which differed from the effect seen using the linear
RNA/DNA substrate (Fig. 3A). Another difference
between the linear hybrid and R-loop substrates was
that the constructs lacking the conserved HBD still
produced an EMSA supershift using the latter sub-
strate (Fig. 4C). The binding studies described above
indicated a role for the catalytic domain in both hy-
brid and dsDNA binding. To investigate this further,





Time (min) 20    20 5     10     15     20     5     10     15    20








KD= 550 ± 24 nM
RNase H1
D252N










Fig. 2. Enzymatic analysis of Dm RNase H1. (A) In a 10 ll reaction, 100 fmol of 30-bp 50-radiolabelled RNA/DNA hybrid were incubated
with 2 fmol of RNase H1 or RNase H1 D252N (catalytically inactive) for the indicated times (min), and separated by non-denaturing gel elec-
trophoresis. In this and subsequent figures RNA/DNA hybrid is denoted by parallel red (online edition only) (RNA) and black (DNA) bars,
with radiolabel indicated by the green asterisk (online edition only). Positive control (þ) used E. coli RNase H. (B) In a 20 ml reaction, 2
pmol of a 30-bp RNA/DNA hybrid were incubated with increasing concentrations of RNase H1 D252N (0, 0.1, 0.5, 1, 2.5, 5 and 10 mM)
and separated by non-denaturating gel electrophoresis. Black arrowheads indicate two different protein–nucleic acid complexes. (C) BLI ana-
lysis of catalytically inactive (D252N) RNase H1 interacting with linear 30-bp RNA/DNA hybrid. Streptavidin sensors were incubated in 80
ml of 25 nM 50 biotinylated hybrid solution. Association was measured by transferring sensor to 80 ml of different concentrations of RNase
H1 D252N solution [0, 10, 40, 60, 80 and 100 nM, as indicated in red text (online edition only)]. Values for the reference sample (0 nM) were
subtracted before plotting. The sensogram displays the baseline, association and dissociation steps, with experimental data shown as black
lines and extrapolated data fitted to heterogeneous (2:1) binding model as red lines (online edition only). The inferred KD for the first binding
step is shown (see Table II for estimated association/dissociation parameters).
Table II. Estimated kinetic parameters
a
of binding of RNase H1 variants to different substrates





Linear hybrid RNase H1 550 6 24 0.22 6 0.063 33 6 1.4 490 6 9.1 18 6 0.061 0.11 6 0.0023
DII/III 110 6 0.75 0.65 6 0.018 220 6 1.4 170 6 0.99 24 6 0.044 0.11 6 0.0029
dsRNA RNase H1 2,200 6 170 750 6 6.2 20 6 15 0.40 6 0.0022 440 6 12 0.30 6 0.0019
DII/III 2,100 6 30 940 6 160 150 6 21 0.66 6 0.11 310 6 1.9 0.62 6 0.030
dsDNA RNase H1 13,000 6 910 340 6 6.6 36 6 0.23 1.8 6 0.026 480 6 8.4 0.62 6 0.075
DII/III 1,900 6 54 120 6 6.3 190 6 5.0 0.63 6 0.0070 370 6 3.5 0.073 6 0.0039
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Effects on nucleic acid-binding of deleting the cata-
lytic domain
We studied the binding properties of D252N-
substituted variants DII–V, DIII–V and DIV/V, lack-
ing the catalytic domain. In EMSA, all of these
variants bound RNA/DNA hybrid and showed a
supershift at high protein concentration (Fig. 5A).
However, none of them bound dsDNA (Fig. 5B and
Supplementary Fig. S6A) or dsRNA (Fig. 5C and
Supplementary Fig. S6B). Quantitative analysis by
BLI (Fig. 5D and E and Table III) showed that these
variants all bound hybrid more tightly than the full-
length protein, with the conserved HBD alone (DII–V)
giving the strongest binding. Overall, these findings con-
firm that the conserved HBD confers tight binding to
hybrid, while the combination of the conserved HBD
and the catalytic domain (plus its immediately upstream
linker) is needed for the much weaker binding to
dsDNA or dsRNA. In contrast, the second HBD weak-
ens binding both to hybrid and to dsDNA (Table II),
consistent with its proposed role in promoting dissoci-
ation from the product and facilitating processivity.
Protein interactors with Dm RNase H1
The properties of the different regions of Dm RNase
H1 are strikingly distinct, perhaps reflecting the fact
Product
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Fig. 3. Biochemical analysis of Dm RNase H1 variants. (A) Enzymatic assay, (B) EMSA and (C, D) BLI, using Dm RNase H1 variants as
indicated. Other details as for Fig. 2, except protein concentrations in (B) were 1 and 10 lM. Positive control in (A) used E. coli RNase H
(þ). For BLI analysis, sensors were incubated in increasing concentrations of RNase H1 variant proteins (DI/II and DI–III: 0, 100, 200, 400,
600, 800 and 1,000 nM; DII/III: 0, 10, 20, 40, 60, 80 and 100 nM). Values for the reference sample (0 nM) were subtracted before plotting.
The red lines (online edition only) of the sensograms shown in (C) are extrapolated data fitted to a monovalent (1:1) binding model (left and
right sensograms, for DI/II and DI–III variants, respectively) or to a heterogeneous (2:1) binding model (middle sensogram, for DII/III vari-
ant). The inferred KD for the first (or only) binding step in each case is shown (see Tables II and III for association/dissociation parameters).
(D) Steady-state analysis of relative equilibrium (Req) plotted against protein concentration, for the variants that fitted a 1:1 binding model.
Although less precise, this method of analysis produced similar estimated dissociation constants 6 standard deviation (SD), as shown.
Table III. Estimated kinetic parameters
a
of binding to 30-bp linear
hybrid
b
, of RNase H1 variants lacking the conserved HBD or cata-
lytic domain
Enzyme variant KD (nM) Kon (1/M*s)*10
23 Koff (1/s)*10
3
DI/II 750 6 32 200 6 8.0 150 6 2.0
DI–III 720 6 13 110 6 1.8 79 6 0.44
DII–V 140 6 0.81 110 6 0.64 15 6 0.029
DIII–V 170 6 0.91 33 6 0.16 5.6 6 0.0093
DIV/V 370 6 3.0 62 6 0.43 23 6 0.055
aBased on BLI, using a (1:1) binding model for these variants,
which gave the best fit. All values are given to two significant
figures.
bThese variants all showed no detectable binding to dsRNA or
dsDNA (see Supplementary Figs S3, S4 and S6).
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that the enzyme must operate in two different cellular
compartments and is implicated in a variety of macro-
molecular processes (see Introduction). To gain fur-
ther insight into the physiological roles of the protein
and its various domains, we initiated a shotgun prote-
omic screen for proteins that bind to the enzyme.
Aiming to identify specific molecular interactors, we
applied a whole-cell cross-linking approach (54), ini-
tially with just one round of immunopurification,
using as bait the full-length protein. As a control to
exclude proteins appearing in the list due to non-
specific proteotoxic stress provoked by overexpression
of a protein targeted to mitochondria, we included
mitochondrially targeted YFP (Supplementary Fig.
S7). Based on the results of the previous study in
which we profiled the dual targeting of the enzyme in
S2 cells (2), we included also the two variants showing
the most compartment-specific localization, M1V (nu-
clear) and M16V (predominantly mitochondrial).
Finally, with the intent of trapping proteins interact-
ing only transiently with Dm RNase H1 during the
catalytic cycle, we included also the D252N variant.
Raw data for each replicate (submitted to MassIVE
data repository, accession number MSV000085303)
are shown in Supplementary Table S2. In each case,
we retained target proteins that were identified in
every replicate experiment with the given bait protein
(n¼ 5 in each case), but which and were absent from
all controls (60). The primary screen revealed a list of
63 proteins that we subdivided into two main groups,
nuclear (Table IV) and mitochondrial candidates
(Table V), based on the major subcellular location of
the protein as currently annotated in Flybase (www.fly
base.org). In general, nuclear candidates were found
using the full-length, D252N and M1V variants,
whereas the mitochondrial candidates were negative
using M1V, but few were detected by M16V either,
possibly an issue with expression level. The nuclear
candidate list included proteins with previously known
or inferred roles in heteroduplex processing and DNA
replication, whereas the mitochondrial candidates cov-
ered a wider spectrum, including many metabolic
enzymes not previously implicated in nucleic acid me-
tabolism. Both lists included the respective,
compartment-specific single-stranded DNA-binding
proteins, RpA-70 (as previously reported in mammals)
(24) and mtSSB. Recently, based on in vitro studies of
the mammalian proteins, it was proposed that mtSSB
and RNase H1 collaborate to generate an RNA pri-
mer that would be used by Polc to initiate mtDNA
replication (10). This, and the paucity of other pro-
teins with known or hypothesized roles in DNA trans-
actions among the mitochondrial candidates, led us to
investigate the interaction between mtSSB and Dm
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Fig. 4. Dm RNase H1 binds but does not degrade non-hybrid double-stranded nucleic acid. (A–C) EMSA and (D–H) nuclease assays using Dm
RNase H1 variants and substrates as indicated, according to the nomenclature of Fig. 2. Protein concentrations in (A–C) as for Fig. 3, other
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Dm mtSSB does not interact directly and stably with
RNase H1 in vivo
Because mass spectrometry revealed mtSSB as a poten-
tial interactor with Dm RNase H1, we performed co-
immunoprecipitation experiments on S2 cells overex-
pressing V5/His epitope-tagged RNase H1, HA
epitope-tagged mtSSB and mtYFP (as control). The
subcellular localization of mtSSB-HA and mtYFP were
validated by immunocytochemistry (Supplementary
Fig. S7). Western blot analysis revealed that the pro-
teins co-immunoprecipitated with RNase H1-V5/His
did not include detectable amounts of mtSSB-HA
(Fig. 6A and Supplementary Fig. S8, left-hand panels).
Similarly, the proteins co-immunoprecipitated with
mtSSB-HA did not include detectable amounts of
RNase H1-V5/His (Fig. 6A and Supplementary Fig.
S8, right-hand panels).
Despite this negative finding with the epitope-
tagged proteins in vivo, we investigated the functional
interactions of the two purified proteins in vitro.
Addition of mtSSB in increasing molar excess (50-fold
and more) showed a trend towards a modest stimula-
tory effect (50%) on the activity of RNase H1,
based on densitometry (see Fig. 6B), although this
was abolished when the assay was conducted in the
presence of ssDNA (Fig. 6B). When a region of
ssDNA was incorporated into the RNase H1 sub-
strate (Fig. 6C), mtSSB had little effect or may even
have inhibited the RNase H1 reaction slightly
(Fig. 6C), while RNase H1 had no reproducible effect
on complex formation between ssDNA and mtSSB
(Fig. 6D). A large molar excess of mtSSB also had
only a modest effect on the formation of complexes
between RNA/DNA hybrid and catalytically inactive
RNase H1 (Fig. 6D), regardless of the presence of
ssDNA.
Discussion
In this study, we evaluated the biochemical properties
of Dm RNase H1, determined the functional roles of
each region of the protein and probed for interacting
proteins from the two cellular compartments in which
RNase H1 is localized. The enzymatic properties of
the Drosophila enzyme are broadly similar to those of
that from humans. However, the two enzymes exhibit
different temperature dependencies, but both are high-
ly temperature sensitive. We identified strong binding
for RNA/DNA hybrid in the conserved HBD (Region
I) and weaker hybrid binding to the catalytic domain
(Region V). The HBD also exhibited weak binding for
dsDNA and dsRNA, but only in constructs also
retaining the catalytic domain. The presence of the
intervening domain (III), which we postulated initially
as being a second HBD based on structure predic-
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Fig. 5. Catalytic domain influences nucleic acid-binding properties of Dm RNase H1. (A–C) EMSA and (D, E) BLI using Dm RNase H1 var-
iants and substrates as indicated, according to the nomenclature of Fig. 2 and 3. The red lines (online edition only) of the sensograms shown
in (D) are extrapolated data fitted to a monovalent (1:1) binding model (see Table III for association/dissociation parameters). (E) Steady-
state analysis of relative equilibrium (Req) plotted against protein concentration. Protein concentrations in (A–C) as for Fig. 3, other details
as for Fig. 2.
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dsDNA binding affinity, but was also required for full
catalytic activity in the presence of the conserved
HBD. These properties are summarized in Fig. 7. We
identified one major interacting protein from mito-
chondria, mtSSB. However, studies in vivo (Fig. 6A
and Supplementary Fig. S8) and in vitro (Fig. 6B–D)
suggest that the interaction is either transient or indir-
ect, requiring the involvement of other proteins or nu-
cleic acid moieties to mediate or stabilize it.
Functional characterization of the domains of Dm
RNase H1
Aiming to understand the role of each domain of the
enzyme, we created a series of deletion constructs,
having divided Dm RNase H1 into five regions, in
order to study the properties conferred by each of
them on the enzyme (Fig. 1). Despite the absence of
conserved amino acids proposed to be involved in
ribonucleotide binding, Region I, the conserved HBD,
bound RNA/DNA hybrid with a similar affinity as
the human HBD (22). The conserved HBD was also
required for dsRNA and dsDNA binding (Fig. 4) but,
in contrast to the human HBD, it requires the add-
itional presence of the catalytic domain (Regions IV
and/or V) for these substrates to be bound (Fig. 5 and
Supplementary Fig. S6). The changes in enzyme kinet-
ics and nucleic acid binding brought about by deletion
of the conserved HBD and the adjacent domains sug-
gest that the HBD contributes to RNA cleavage by
promoting interaction with heteroduplex. In addition,
we observed that the ablation of the HBD abolishes
supershifting upon EMSA analysis, suggesting that
two protein monomers may associate with a single
substrate, conferring processivity to the enzyme, as
previously suggested for the mammalian enzyme (23).
Regions II and III initially attracted our attention,
due to variability in length and composition among
eukaryotes. In the Drosophila enzyme this extended
linker region is particularly long (Fig. 1), with a pre-
dicted isoelectric point (pI ¼ 5.18) similar to that of
mammals or zebrafish, but lower than in Xenopus tro-
picalis (pI ¼ 9.11) or C.elegans (pI ¼ 6.79). Moreover,
structural modelling suggested that Region III may
constitute a second HBD (Supplementary Fig. S1C).
We were unable to study its properties in isolation,
due to its insolubility, possibly indicating that its fold-
ing depends on the adjacent domains. However, our
other data (Tables II and III) indicate that, whereas
this region actually weakens the overall hybrid bind-
ing of the enzyme (Fig. 3), it enhances catalysis
(Table I). Although a conclusive interpretation of
these findings must await full elucidation of the reac-
tion mechanism of Dm RNase H1, it is tempting to
suggest that the HBD-like fold of Region III is involved
in shuttling substrate from the conserved HBD to the
catalytic domain, as part of the processivity mechanism.
Its deletion would thus promote tight and persistent hy-
brid binding by the conserved HBD, leading to a lower
catalytic throughput. An alternative explanation for the
findings might be that the length of the extended linker
per se determines the catalytic activity and binding affin-
ity of the enzyme. In other words, a long linker allows
the catalytic domain to interact processively or succes-
sively with substrate, while also influencing binding (a
‘running dog on a leash’ model). Whether the ‘second
HBD’ actually binds nucleic acid, even transiently, and
whether its predicted fold is functionally important,
must await detailed structural analysis and further muta-
genic studies of the enzyme, using crystallography. The
differences in the binding properties of the enzyme
in vitro, using the linear hybrid (Fig. 2) and R-loop sub-
strates (Fig. 3), may reflect functionally important differ-
ences in vivo, such as in the removal of persistent
heteroduplex regions that arise during transcription, ver-
sus the processing of DNA replication intermediates
(e.g. the formation and removal of leading- and lagging-
strand primers).
The catalytic domain was predicted to adopt a simi-
lar fold as previously observed in viruses (61), bacteria
(25, 26, 62, 63) and mammals (27), and includes the
conserved DEDD motif (Supplementary Fig. S1),
from which residue D252 was shown to be essential
for activity, as in other organisms (34). Importantly,
the catalytic domain was required for the 2:1 binding
model (Table III), but not for the supershift seen in
EMSA (Fig. 5A), for which the conserved HBD alone
was sufficient. This suggests that the reaction involves
not only the binding of a second protein molecule but
also, potentially, a conformational change dependent
on the catalytic domain, which may enable the second
protein moiety to bind.
To test these ideas in the future, it may prove useful
to create chimeric enzymes, for example inserting the
second HBD from the Drosophila enzyme into the
Table IV. List of nuclear candidates for Dm RNase H1 interactors
Category CG numbera Official name, gene symbola Human orthologuea Mean PSM
factor
Detected by which variant(s)?
RNase H1 D252N M1V M16V
Genome maintenance
and transcription
CG10279 Rm62, isoform H, Rm62 DDX5, DDX17 9 Yes Yes Yes No
CG9633 Replication protein A 70, RpA-70 RPA1 6.6 No No Yes No
CG7831 Non-claret disjunctional, ncd KIFC1 4 No No Yes No
CG5499 Histone H2A variant, His2Av H2AFV, H2AFZ 3 No No Yes No
CG4747 Nucleosome-destabilizing factor, Ndf GLYR1 2.6 No No Yes No
CG4206 Minichromosome maintenance 3, Mcm3 MCM3 1.8 No No Yes No
CG7538 Minichromosome maintenance 2, Mcm2 MCM2 1 No No Yes No
Cell cycle progression CG6392 CENP-meta, cmet CENPE 1 Yes No No No
Other CG5436 Heat shock protein 68, Hsp68 HSPA1A/HSPA1B 4.8 Yes No Yes Yes
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Table V. List of mitochondrial candidates for Dm RNase H1 interactors
Category CG numbera Official name, gene symbola Human
orthologuea
Mean PSM factor Detected by which variant(s)?
RNase H1 D252N M1V M16V
Metabolism CG10622 Succinyl-coenzyme A synthetase b
subunit, GDP-forming, ScsbG
SUCLG2 9.6 Yes Yes No Yes
CG7010 Pyruvate dehydrogenase E1 com-
ponent subunit alpha, Pdha
PDHA2 7.6 Yes Yes No Yes
CG8778 CG8778 [enoyl-CoA hydratase],
CG8778
AUHb 6.2 Yes Yes No No
CG7920 CG7920, isoform A, CG7920 [MATN2]c 6 Yes Yes No Yes
CG6439 Isocitrate dehydrogenase 3b,
Idh3b
IDH3B 6 Yes No No No
CG12262 Medium-chain acyl-CoA dehydro-
genase, Mcad
ACADM 5 Yes No No No
CG4703 Arc42 [Short-chain acyl-CoA de-
hydrogenase], Arc42
ACADS 4.8 Yes Yes No Yes
CG5889 Malic enzyme, Men-b ME3 4.8 Yes No No No
CG9006 Enigma, Egm ACAD9 3.8 Yes Yes No No
CG5320 Glutamate dehydrogenase, Gdh GLUD1 3.6 Yes No No No
CG5599 CG5599, CG5599 DBTd 3.4 Yes No No No
CG5590 CG5590, CG5590 HSDL2 3 Yes Yes No No
CG10639 L-2-hydroxyglutarate dehydrogen-
ase, L2HGDH
L2HGDH 3 Yes No No No
CG16935 CG16935 [Trans-2-enoyl-CoA re-
ductase (NADPH)], CG16935
MECR 2.6 Yes Yes No No
CG1236 CG1236 [Glyoxylate and hydroxy-
pyruvate reductase], CG1236
GRHPR 2.6 Yes No No No
CG4860 CG4860 [Short-chain acyl-CoA
dehydrogenase], CG4860
ACADS 2.2 Yes No No No
CG10194 CG10194, CG10194 NUDT19 2.2 Yes No No No
CG5028 CG5028, [Isocitrate dehydrogen-
ase (NAD(þ))], isoform C,
CG5028
IDH3G 2 Yes Yes No No
CG7842 bad egg, beg MCAT 2 Yes No No No
CG12140 Electron transfer flavoprotein-ubi-
quinone oxidoreductase, Etf-
QO
ETFDH 1.8 Yes No No No
CG4094 Fumarase 1, Fum1 FH 1.8 Yes No No No
CG10672 CG10672 [Carbonyl reductase
(NADPH)], CG10672
DHRS4 1.6 Yes No No No
CG3267 Methylcrotonoyl-CoA carboxylase
2, Mccc2
MCCC2 1.6 Yes No No No
Translation CG6050 mitochondrial elongation factor
Tu, mEFTu1
TUFM 8.2 Yes Yes No Yes
CG6412 Mitochondrial elongation factor
Ts, mEFTs
TSFM 2.4 Yes Yes No No
CG2957 Mitochondrial ribosomal protein
S9, mRpS9
MRPS9 2.2 Yes No No No
CG13126 CG13126, CG13126 METTL17 2 Yes No No No
CG5242 Mitochondrial ribosomal protein
L40, mRpL40
MRPL40 1.6 Yes No No No
CG5012 Mitochondrial ribosomal
proteinL12, mRpL12
MRPL12 1.4 No Yes No No
CG7494 Mitochondrial ribosomal protein
L1, mRpL1
MRPL1 1.2 Yes No No No
Protein import and
processing
CG11779 CG11779, CG11779 TIMM44 8.2 Yes Yes No No
CG8728 CG8728, CG8728 PMPCA 6.6 Yes Yes No No
CG6155 Roe1, Roe1 GRPEL1 3 Yes Yes No No
CG3107 CG3107, CG3107 PITRM1 2 Yes No No No
OXPHOS CG2286 NADH-ubiquinone oxidoreduc-
tase 75 kDa subunit, ND-75
NDUFS1 7.6 Yes Yes No No
CG1970 NADH dehydrogenase (ubiquin-
one) 49 kDa subunit, ND-49
NDUFS2 2.2 Yes Yes No No
CG14724 Cytochrome c oxidase subunit 5A,
COX5A
COX5A 1.4 Yes No No No
CG10340 CG10340, CG10340 ATPAF1 1 Yes No No No
CG3214 NADH dehydrogenase (ubiquin-
one) B17.2 subunit, ND-B17.2
NDUFA12 1 Yes No No No
tRNA metabolism CG7479 Leucyl-tRNA synthetase, mito-
chondrial, LeuRS-m
LARS2 5.4 Yes No No No
CG16912 Tyrosyl-tRNA synthetase, mito-
chondrial, TyrRS-m
YARS2 1.2 Yes No No No
(continued)
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human one. However, since the activity of any domain
of a protein is potentially influenced by any other, all
possible chimeric constructs between the two enzymes
should be tested, both with and without the additional
HBD. This is particularly important for a processive
enzyme like RNase H1, where each domain can be
considered as one of its crucial moving parts.
Functional comparison with RNase H1 from other
species
In this study we adopted the same approach, using
purified proteins, as has been successfully employed
by others to study human RNase H1 and other
enzymes of mitochondrial nucleic acid metabolism
(64–66). Most studies of eukaryotic RNase H1 have
focused on the enzymes from yeast and from humans,
while little was known about the function, role and
biochemical properties of the Drosophila enzyme (2,
27, 47). We initially characterized the enzymatic activ-
ity of Dm RNase H1 at 30C, revealing slightly differ-
ent kinetic parameters from those of the human
enzyme, studied previously at 37C (34, 45); 30C has
widely been used as a reference temperature for stud-
ies of Drosophila enzymes, notably those involved in
mtDNA metabolism. It represents a temperature
about 10–12C warmer than the typical physiological
temperature of the fly. However, assuming that, like
their mammalian counterparts, Drosophila mitochon-
dria are 10–12C warmer than the cells and tissues in
which they function (67), 30C should represent an
optimal temperature at which to study mitochondri-
ally localized enzymes. When we compared the human
and Drosophila enzymes we found their properties to
be highly influenced by temperature, with the human
enzyme essentially inactive at 30C, but the
Drosophila enzyme exhibiting a much lower substrate
affinity (higher KM) at 37
C than at 30C. At its pre-
sumed optimal temperature of 30C, the Drosophila
enzyme displayed a markedly higher affinity and cata-
lytic turnover rate than the human enzyme at 37C
(Table I). However, given the marked temperature
sensitivity of both enzymes, and the fact that the
in vivo operating temperature of the human enzyme in
mitochondria is probably much closer to 50C than to
37C (67), the two enzymes may have more similar
properties than is apparent. Note also that the cell nu-
cleus should be much closer to ambient temperature
(in the fly) or to 37C in humans, such that the enzym-
atic properties of RNase H1 in the nucleus may differ
substantially.
Similar caution should apply to measurements of af-
finity constants, especially given the uncertainties raised
by the use of different methods in the various studies.
Here, applying BLI using the D252N-substituted en-
zyme, we inferred a KD value intermediate between
those previously reported for human (34) and E. coli
RNase H1 (67). Previously, BLI has been used to meas-
ure nucleic acid–protein interactions, obtaining similar
values as with other approaches (69), and has been spe-
cifically applied to the study of Polc (53).
Mammalian, yeast and E. coli RNase H1 bind
dsRNA, but only the enzyme from the archaeon
Sulfolobus tokodaii 7 has been demonstrated to digest
this substrate (70). In the present study we found that
Dm RNase H1 also binds dsRNA and dsDNA (Fig. 4
and Table II), respectively, 10-fold and 100-fold
less tightly than RNA/DNA hybrid, but does not di-
gest these substrates, nor does it bind or digest
ssRNA or ssDNA, properties shared with the human
and E. coli enzymes (64).
In a previous study, RNase H1 from the budding









Mean PSM factor Detected by which variant(s)?
RNase H1 D252N M1V M16V
mtDNA maintenance CG4337 Mitochondrial single-stranded
DNA-binding protein, mtSSB
SSBP1 4.2 Yes Yes No No
Oxidative stress CG5826 Peroxiredoxin 3, Prx3 PRDX3 3 Yes Yes No No
CG7217 Peroxiredoxin 5, Prx5 PRDX5 3 Yes Yes No No
CG10964 Sniffer, sni RDH5 1 Yes No No No
Other CG8479 Optic atrophy 1 orthologue, iso-
form D, Opa1
OPA1 6.4 Yes No No No
CG14434 CG14434, CG14434 4 Yes No No No
CG13850 CG13850, CG13850 TBRG4 4 Yes No No No
CG2794 CG2794, CG2794 3.4 Yes No No No
CG11624 Ubiquitin-63E, Ubi-p63E UBC 3 No Yes No No
CG5844 Spliceosome–ribosome linker pro-
tein, Srlp
2.6 Yes Yes No No
CG5915 Rab7, Rab7 RAB7A 1.8 Yes No No Yes
CG11267 CG11267 [Hsp10 chaperonin sub-
unit], CG11267
HSPE1 1.4 Yes Yes No No
CG8993 CG8993, CG8993 TXN2 1 Yes No No No
aBased on current information in Flybase (flybase.org). Some of these genes are still officially identified only by CG numbers, although
orthology indicates a clear enzymatic function also reported in Flybase, and shown here [in brackets].
bHuman orthologue is an RNA-binding variant of the metabolic enzyme.
cClosest match but does not fulfil all criteria for being a true orthologue.
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binding domains located in the N-terminal region (56)
(see Fig. 1),with the more N-terminally located such
region showing a much higher affinity for substrate.
This raises the question as to whether the architecture
and suggested reaction mechanism of the Dm enzyme,
with two HBDs, might also apply in yeast. However,
in other respects the Dm enzyme differs fundamentally
from that of S. cerevisiae, having much lower affinity
for dsRNA than for RNA/DNA hybrid, while the
‘HBD’ of the yeast enzyme actually binds dsRNA
more tightly than hybrid (57). Furthermore the cata-
lytic domain of the Dm enzyme binds hybrid on its
own, and is required for binding to dsRNA, while the
enzyme from S. cerevisiae shares neither property
(57). Thus, the functional properties of the two
enzymes in vivo are likely to differ substantially.
Significance of RNase H1 interactors
RNase H1 has been implicated in several processes in
different sub-cellular compartments. Our mass spec-
trometry analysis of proteins associating with RNase
H1 after cross-linking revealed a list of potential inter-
actors in the nucleus, as well as in mitochondria, in
both of which single-stranded DNA-binding proteins
were prominent. In mammals, RPA (replication pro-
tein A) has been shown to recruit RNase H1 to R-
loops and stimulate its enzymatic activity (24), via an
interaction with the HBD. Such an interaction facili-
tates the role of the enzyme in heteroduplex surveil-
lance and also, potentially, in DNA maintenance. SSB
and RNase H have also been reported to interact in
E. coli (71), in this case via the catalytic core, because
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Fig. 6. Mitochondrial single-strand DNA-binding protein does not stimulate RNase H1 activity in vitro. (A) Western blots of immunoprecipi-
tates from S2 cells co-expressing RNase H1-V5/His and mtSSB-HA or mtSSB-HA and mtYFP. Immunoprecipitates using anti-V5 (left-hand
panels) or anti-HA (right-hand panels) from cells transfected as indicated and probed as shown to the right of blot panels. All protein
extracts were tracked by successive sampling during the procedure, indicated as follows: bc, before cross-linking; ac, after cross-linking; p,
pellet; ft, flowthrough; w1, 2 and 3, washes; e, eluate, still cross-linked; eþ, eluate after reversal of cross-linking. Samples were imaged by
Western blot using anti-HA for detecting mtSSB-HA, anti-6x-His tag for detecting RNase H1-V5/His and anti-GFP for detecting YFP. (B,
C) Nuclease assays using 0.1 nM of Dm RNase H1 and radiolabelled substrates as illustrated, according to the nomenclature of Fig. 2, pre-
incubated with increasing concentration of mtSSB (0, 5, 10, 25, 50, 100, 250 and 500 nM), without (B, left panel and C) or with (B, right
panel) a 60-nt ssDNA oligonucleotide for 10 min. Densitometric analysis of the gel image shown in (B) indicated a 55% stimulation in activ-
ity at the highest dose of SSB used, compared with no SSB (based on the relative intensities of the substrate band and low-molecular-weight
product). Substrate in (C) had a 60-nt ssDNA 30 overhang. (D) EMSA reactions with 1 mM RNase H1 D252N variant, incubated with
increasing concentrations (1, 2.5, 5, 7.5 lM) of free mtSSB (left panel) or ssDNA þ mtSSB complex (right panel), for 10 min at room tem-
perature. Arrowheads indicate the complex formed between RNase H1 and the 30-bp RNA/DNA hybrid (black) and between mtSSB and
the 60-nt ssDNA (red, online edition only).
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was one of the top nuclear hits in our screen for inter-
acting proteins (Table IV), which also yielded two
subunits of the nuclear replicative helicase, Mcm2 and
Mcm3 (71, 72), while RPA has been implicated in nu-
clear processes other than DNA replication (74, 75).
We also identified mtSSB, the functional homologue
of RPA in mitochondria, as a prominent hit
(Table V). mtSSB is a well-characterized component
of the mtDNA replication machinery (76), while
RNase H1 in Drosophila has also been inferred to
play a role in mtDNA replication fork progression
(2). Furthermore, mtSSB and RNase H1 have been
proposed to co-operate in the initiation of mtDNA
replication (10), which spurred us to examine the pos-
sible interaction between them in more detail. The two
proteins did not co-immunoprecipitate when overex-
pressed together in vivo (Fig. 6A and Supplementary
Fig. S8), nor did enzymatic assays and EMSA reveal
convincing evidence for any direct interaction in vitro
(Fig. 6B–D), apart from a modest stimulation or pos-
sible inhibition of the enzyme, depending on the spe-
cific substrate (Fig. 6B and C). Although
overexpression in vivo and in vitro analysis of the
properties of bacterially expressed proteins is subject
to different potential artefacts, the fact that neither
approach strongly supported a direct and stable inter-
action implies that mtSSB and Dm RNase H1 most
likely interact indirectly or transiently in vivo, requir-
ing an unidentified partner protein or nucleic acid
moiety to have enabled their co-detection by mass
spectrometry. This does not exclude that the two pro-
teins may co-operate as suggested (10), with mtSSB
binding to the single-stranded DNA displaced at an
R-loop, promoting RNase H1 recruitment that would
partially digest the annealed RNA, thus creating a 30-
end accessible for extension by Polc. However, it
would imply that at least one additional partner
would be required for such a recruitment to occur.
This partner cannot simply be ssDNA, because it did
not facilitate direct interaction between the proteins
in vitro (Fig. 6B–D). It is also possible that mtSSB
and RNase H1 co-localize at the replication origin, at
replication forks and at dispersed R-loops only by vir-
tue of their substrates (ssDNA and RNA/DNA hy-
brid) being juxtaposed at these sites, and thus that
their close association is purely accidental.
Importantly, negative findings such as ours, even
though supported by multiple approaches, may be er-
roneous if the conditions for analysis in vitro are in-
appropriate. Future experiments using different
methods may be needed to confirm (or revise) the ap-
parent absence of direct interaction. The functional
interactions of mtSSB with other mitochondrial repli-
cation proteins, such as Polc (77) or mtDNA-helicase
(78), require low salt conditions, similar to those used
here, which yielded negative findings. However, it is
possible that some other feature of the intramitochon-
drial environment is required to maintain mtSSB/
RNase H1 links in Drosophila.
In human cells, mtSSB has been reported to localize
partially to RNA granules (79), while defects in the
machinery of RNA processing and degradation result
in the accumulation of persistent R-loops, resulting in
RNase H1 recruitment to nucleoids (80). In an earlier
study, vertebrate RNase H1 was not observed as a
nucleoid protein (81), consistent with its interactions
with mitochondrial replication and RNA processing
enzymes being transient, and mediated by its associ-
ation with RNA/DNA hybrid substrate, rather than
by direct protein–protein interactions.
Among other nuclear hits, we identified a second
component of the R-loop processing machinery, the
amino acid                      17                        65 87                     142           179 333
Extended linker
region                                              I II                    III                  IV V
MTS         HBD            short     ”second HBD” short                         catalytic
linker                                  linker
enhances      region V                RNase H activity
RNase H     solubility
activity
strong weak
hybrid binding hybrid binding
required for weakens                                required for dsDNA and
dsDNA and hybrid and                                  dsRNA binding
dsRNA binding dsDNA
binding
Fig. 7. Functional summary diagram of Dm RNase H1. Schematic representation of Drosophila melanogaster RNase H1. The five regions are
bounded as shown, by amino acids 17, 65, 87, 142, 179 and 333. The black box represents the conserved HBD, the hatched box the second
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RNA helicase Rm62, the Drosophila homologue of
human DDX5. In flies Rm62 is involved in transcrip-
tional deactivation (82) and in the maintenance of
chromatin states (83, 84), while human DDX5 func-
tions in R-loop processing (85) and may perform a
wide variety of additional role (86–88). The appear-
ance of Rm62 in the list suggests a potential inter-
action between two independent machineries to
resolve R-loops. The list of mitochondrial candidates
was much longer, and included, as a prominent class,
many metabolic enzymes involved in core processes
such as fatty acid oxidation, the TCA cycle and
OXPHOS, as well as some proteins involved in mito-
chondrial translation. Metabolic enzymes have been
previously reported as at least peripheral components
of nucleoids in many species, and there is on-going de-
bate as to whether this association is meaningful. In
regard to the present study, the question arises as to
whether they represent ‘real’ interactors with RNase
H1 or are just passenger proteins brought along by
cross-linking in a protein-rich environment. Some
hits, such as the fly orthologues of human TIMM44,
GRPEL1, PITRM1 and PMPCA, are likely to be
artefacts of overexpression, resulting from the machin-
ery of protein import and processing becoming over-
whelmed, even though these proteins did not appear
in the mtYFP negative control list. Given the fact that
the mitochondrial candidate list is ‘over-inclusive’ in
this manner, and that many nuclear hits are congruent
with previous data or with assumptions made on the
basis of such data, the absence of any known compo-
nent of the apparatus of mitochondrial nucleic acid
metabolism other than mtSSB is striking.
Note that a number of other possible candidates do
not figure in Tables IV and V because of the strict ex-
clusion criteria, i.e. they were found in at least one
control replicate (see Supplementary Table S2).
Prominent among these was P32 (CG6459 in
Drosophila), reported as being present in both the
mitochondria and nucleus and implicated in diverse
processes, and which was previously found to associ-
ate with RNase H1 in mammals and proposed to
stimulate its activity (45). While it may be enriched in
the fraction associating with RNase H1, it is not spe-
cific to this fraction.
Having undertaken this study to follow up previous
observations that a deficiency of Dm RNase H1
results in characteristic abnormalities of mtDNA rep-
lication and transcription (2), the absence of replica-
tion and transcription proteins other than mtSSB
from the list of mitochondrial positives was unexpect-
ed. Furthermore, the clinical features manifested by
patients with mutations in the RNASEH1 gene resem-
ble those associated with other disorders caused by
defects in the mtDNA replication apparatus (37–39).
One simple explanation is that RNase H1 does not
interact directly with replication proteins, and that the
effects of its deficiency on mtDNA replication are sec-
ondary to a failure to process R-loops and other
hybrid-containing structures. In other words, RNase
H1 may function independently and not be part of the
mitochondrial replisome, transcriptional machinery or
any other protein complex within or associated with
the nucleoid.
Supplementary Data
Supplementary Data are available at JB Online.
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discussions, Juha Määttä for guidance with BLI, Tea Tuomela,
Eveliina Teeri and Merja Jokela for technical assistance and Troy
Faithfull for critical reading of the manuscript.
Funding
This work was supported by Academy of Finland [Centre of
Excellence Grant 272376 and Academy Professorship Grant
256615 to H.T.J. and Finland Distinguished Professorship 139587
to L.S.K], the Finnish Cultural Foundation [Grant 00190260 to
J.M.G.d.C.], Tampere University and the Sigrid Juselius
Foundation. The work used core facilities for proteomics in the
Institute of Biotechnology (Helsinki), as well as for imaging and





1. Cerritelli, S.M. and Crouch, R.J. (1998) Cloning, ex-
pression, and mapping of ribonucleases H of human
and mouse related to bacterial RNase HI. Genomics 53,
300–307
2. González de Cózar, J.M., Gerards, M., Teeri, E.,
George, J., Dufour, E., Jacobs, H.T., and J~oers, P.
(2019) RNase H1 promotes replication fork progres-
sion through oppositely transcribed regions of
Drosophila mitochondrial DNA. J. Biol. Chem. 294,
4331–4344
3. Ohtani, N., Haruki, M., Morikawa, M., Crouch, R.J.,
Itaya, M., and Kanaya, S. (1999) Identification of the
genes encoding Mn2þ-dependent RNase HII and
Mg2þ-dependent RNase HIII from Bacillus subtilis:
classification of RNases H into three families.
Biochemistry 38, 605–618
4. Murante, R.S., Henricksen, L.A., and Bambara, R.A.
(1998) Junction ribonuclease: an activity in Okazaki
fragment processing. Proc. Natl Acad. Sci. USA 95,
2244–2249
5. Cerritelli, S.M., Frolova, E.G., Feng, C., Grinberg, A.,
Love, P.E., and Crouch, R.J. (2003) Failure to produce
mitochondrial DNA results in embryonic lethality in
Rnaseh1 null mice. Mol. Cell 11, 807–815
6. Ruhanen, H., Ushakov, K., and Yasukawa, T. (2011)
Involvement of DNA ligase III and ribonuclease H1 in
mitochondrial DNA replication in cultured human
cells. Biochim. Biophys. Acta 1813, 2000–2007
7. Holmes, J.B., Akman, G., Wood, S.R., Sakhuja, K.,
Cerritelli, S.M., Moss, C., Bowmaker, M.R., Jacobs,
H.T., Crouch, R.J., and Holt, I.J. (2015) Primer reten-
tion owing to the absence of RNase H1 is catastrophic
for mitochondrial DNA replication. Proc. Natl Acad.
Sci. USA 112, 9334–9339
8. Parajuli, S., Teasley, D.C., Murali, B., Jackson, J.,
Vindigni, A., and Stewart, S.A. (2017) Human ribo-
nuclease H1 resolves R-loops and thereby enables








ational Library of H
ealth Sciences user on 04 January 2021
progression of the DNA replication fork. J. Biol.
Chem. 292, 15216–15224
9. Zhao, H., Zhu, M., Limbo, O., and Russell, P. (2018)
RNase H eliminates R-loops that disrupt DNA replica-
tion but is nonessential for efficient DSB repair.
EMBO Rep. 19, e45335
10. Posse, V., Al-Behadili, A., Uhler, J.P., Clausen, A.R.,
Reyes, A., Zeviani, M., Falkenberg, M., and
Gustafsson, C.M. (2019) RNase H1 directs
origin-specific initiation of DNA replication in human
mitochondria. PLoS Genet. 15, e1007781
11. Tan-Wong, S.M., Dhir, S., and Proudfoot, N.J. (2019)
R-Loops promote antisense transcription across the
mammalian genome. Mol. Cell 76, 600–616.e6
12. Lai, F., Damle, S.S., Ling, K.K., and Rigo, F. (2020)
Directed RNase H cleavage of nascent transcripts
causes transcription termination. Mol. Cell 77,
1032–1043
13. Reyes, A., Rusecka, J., Tonska, K., and Zeviani, M.
(2020) RNase H1 regulates mitochondrial transcription
and translation via the degradation of 7S RNA. Front.
Genet. 10, 1–11
14. Briggs, E., Crouch, K., Lemgruber, L., Lapsley, C.,
and McCulloch, R. (2018) Ribonuclease H1-targeted
R-loops in surface antigen gene expression sites can
direct trypanosome immune evasion. PLoS Genet. 14,
e1007729
15. Yu, K. and Lieber, M.R. (2019) Current insights into
the mechanism of mammalian immunoglobulin class
switch recombination., Crit. Rev. Biochem. Mol. Biol.
54, 333–351
16. Tannous, E., Kanaya, E., and Kanaya, S. (2015) Role
of RNase H1 in DNA repair: removal of single ribonu-
cleotide misincorporated into DNA in collaboration
with RNase H2. Sci. Rep. 5, 9969
17. Amon, J.D. and Koshland, D. (2016) RNase H enables
efficient repair of R-loop induced DNA damage. Elife
5, e20533
18. Arora, R., Lee, Y., Wischnewski, H., Brun, C.M.,
Schwarz, T., and Azzali, C.M. (2014) RNaseH1 regu-
lates TERRA-telomeric DNA hybrids and telomere
maintenance in ALT tumour cells. Nat. Commun. 5,
1–11
19. Billard, P. and Poncet, D.A. (2019) Replication stress
at telomeric and mitochondrial DNA: common origins
and consequences on ageing. Int. J. Mol. Sci. 20, 4959
20. Cerritelli, S.M. and Crouch, R.J. (2009) Ribonuclease
H: the enzymes in eukaryotes. FEBS J. 276, 1494–1505
21. Kochiwa, H., Tomita, M., and Kanai, A. (2007)
Evolution of ribonuclease H genes in prokaryotes to
avoid inheritance of redundant genes. BMC Evol. Biol.
7, 1–13
22. Nowotny, M., Cerritelli, S.M., Ghirlando, R.,
Gaidamakov, S.A., Crouch, R.J., and Yang, W. (2008)
Specific recognition of RNA/DNA hybrid and en-
hancement of human RNase H1 activity by HBD.
EMBO J. 27, 1172–1181
23. Gaidamakov, S.A., Gorshkova, I.I., Schuck, P.,
Steinbach, P.J., Yamada, H., Crouch, R.J., and
Cerritelli, S.M. (2005) Eukaryotic RNases H1 act proc-
essively by interactions through the duplex
RNA-binding domain. Nucleic Acids Res. 33,
2166–2175
24. Nguyen, H.D., Yadav, T., Giri, S., Saez, B., Graubert,
T.A., and Zou, L. (2017) Functions of replication pro-
tein A as a sensor of R loops and a regulator of
RNaseH1. Mol. Cell 65, 832–847.e4
25. Yang, W., Hendrickson, W.A., Crouch, R.J., and
Satow, Y. (1990) Structure of ribonuclease H phased at
2 A resolution by MAD analysis of the selenome-
thionyl protein. Science 249, 1398–1405
26. Katayanagi, K., Miyagawa, M., Matsushima, M.,
Ishikawa, M., Kanaya, S., Ikehara, M., Matsuzaki, T.,
and Morikawa, K. (1990) Three-dimensional structure
of ribonuclease H from E. coli. Nature 347, 306–309
27. Nowotny, M., Gaidamakov, S.A., Ghirlando, R.,
Cerritelli, S.M., Crouch, R.J., and Yang, W. (2007)
Structure of human RNase H1 complexed with an
RNA/DNA hybrid: insight into HIV reverse transcrip-
tion. Mol. Cell 28, 264–276
28. Ishikawa, K., Okumura, M., Katayanagi, K., Kimura,
S., Kanaya, S., Nakamura, H., and Morikawa, K.
(1993) Crystal structure of ribonuclease H from
Thermus thermophilus HB8 refined at 2.8 A resolution.
J. Mol. Biol. 230, 529–542
29. Nowotny, M., Gaidamakov, S.A., Crouch, R.J., and
Yang, W. (2005) Crystal structures of RNase H bound
to an RNA/DNA hybrid: substrate specificity and
metal-dependent catalysis. Cell 121, 1005–1016
30. Lim, D., Gregorio, G.G., Bingman, C., Martinez-
Hackert, E., Hendrickson, W.A., and Goff, S.P. (2006)
Crystal structure of the moloney murine leukemia virus
RNase H domain. J. Virol. 80, 8379–8389
31. Chattopadhyay, D., Finzel, B.C., Munson, S.H.,
Evans, D.B., Shama, S.K., Strakalaitis, N.A., Brunner,
D.P., Eckenrode, F.M., Dauter, Z., Betzel, C., and
Einspahr, H.M. (1993) Crystallographic analyses of an
active HIV-1 ribonuclease H domain show structural
features that distinguish it from the inactive form. Acta
Crystallogr. D Biol. Crystallogr. 49, 423–427
32. Hizi, A. and Herschhorn, A. (2008) Retroviral reverse
transcriptases (other than those of HIV-1 and murine
leukemia virus): a comparison of their molecular and
biochemical properties. Virus Res. 134, 203–220
33. Hyjek, M., Figiel, M., and Nowotny, M. (2019)
RNases H: structure and mechanism. DNA Repair 84,
102672
34. Wu, H., Lima, W.F., and Crooke, S.T. (2001)
Investigating the structure of human RNase H1 by
site-directed mutagenesis. J. Biol. Chem. 276,
23547–23553
35. Cerritelli, S.M., Fedoroff, O.Y., Reid, B.R., and
Crouch, R.J. (1998) A common 40 amino acid motif in
eukaryotic RNases H1 and caulimovirus ORF VI pro-
teins binds to duplex RNAs. Nucleic Acids Res. 26,
1834–1840
36. Filippov, V., Filippova, M., and Gill, S.S. (2001)
Drosophila RNase H1 is essential for development but
not for proliferation. Mol. Gen. Genomics 265, 771–777
37. Reyes, A., Melchionda, L., Nasca, A., Carrara, F.,
Lamantea, E., Zanolini, A., Lamperti, C., Fang, M.,
Zhang, J., Ronchi, D., Bonato, S., Fagiolari, G.,
Moggio, M., Ghezzi, D., and Zeviani, M. (2015)
RNASEH1 mutations impair mtDNA replication and
cause adult-onset mitochondrial encephalomyopathy.
Am. J. Hum. Genet. 97, 1–8
38. Carre~no-Gago, L., Blázquez-Bermejo, C., Dı́az-
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